Expression of Concern on "The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone".
出版信息
J Diabetes Res. 2019 Jun 16;2019:2938413. doi: 10.1155/2019/2938413. eCollection 2019.
Abstract
摘要
相似文献
1
Expression of Concern on "The Novel Oral Drug Subetta Exerts an Antidiabetic Effect in the Diabetic Goto-Kakizaki Rat: Comparison with Rosiglitazone".关于“新型口服药物Subetta对糖尿病Goto-Kakizaki大鼠具有抗糖尿病作用：与罗格列酮的比较”的关注声明
J Diabetes Res. 2019 Jun 16;2019:2938413. doi: 10.1155/2019/2938413. eCollection 2019.
2
The novel oral drug Subetta exerts an antidiabetic effect in the diabetic Goto-Kakizaki rat: comparison with rosiglitazone.新型口服药物 Subetta 在糖尿病 Goto-Kakizaki 大鼠中发挥抗糖尿病作用：与罗格列酮的比较。
J Diabetes Res. 2013;2013:763125. doi: 10.1155/2013/763125. Epub 2013 May 8.
3
Increased expression of adenylyl cyclase isoforms in the adrenal gland of diabetic Goto-Kakizaki rat.糖尿病Goto-Kakizaki大鼠肾上腺中腺苷酸环化酶同工型表达增加。
Appl Immunohistochem Mol Morphol. 2002 Dec;10(4):387-92. doi: 10.1097/00129039-200212000-00017.
4
Long-term renal changes in the Goto-Kakizaki rat, a model of lean type 2 diabetes.Goto-Kakizaki大鼠（一种瘦型2型糖尿病模型）的长期肾脏变化
Nephrol Dial Transplant. 2004 May;19(5):1092-7. doi: 10.1093/ndt/gfh107. Epub 2004 Feb 19.
5
Abnormal myosin phosphatase targeting subunit 1 phosphorylation and actin polymerization contribute to impaired myogenic regulation of cerebral arterial diameter in the type 2 diabetic Goto-Kakizaki rat.异常的肌球蛋白磷酸酶靶向亚基1磷酸化和肌动蛋白聚合作用导致2型糖尿病Goto-Kakizaki大鼠脑动脉直径的肌源性调节受损。
J Cereb Blood Flow Metab. 2017 Jan;37(1):227-240. doi: 10.1177/0271678X15622463. Epub 2015 Dec 31.
6
Dysfunction of soluble guanylyl cyclase in aorta and kidney of Goto-Kakizaki rats: influence of age and diabetic state.Goto-Kakizaki大鼠主动脉和肾脏中可溶性鸟苷酸环化酶功能障碍：年龄和糖尿病状态的影响。
Nitric Oxide. 2002 Feb;6(1):85-95. doi: 10.1006/niox.2001.0363.
7
Pharmacological properties, functional alterations and gene expression of muscarinic receptors in young and old type 2 Goto-Kakizaki diabetic rat bladders.年轻和老年2型Goto-Kakizaki糖尿病大鼠膀胱中M胆碱能受体的药理特性、功能改变及基因表达
J Urol. 2008 Dec;180(6):2701-5. doi: 10.1016/j.juro.2008.08.002. Epub 2008 Oct 31.
8
Modeling disease progression and rosiglitazone intervention in type 2 diabetic Goto-Kakizaki rats.模拟 2 型糖尿病 Goto-Kakizaki 大鼠的疾病进展和罗格列酮干预。
J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.
9
Extract Exerts an Anti-Diabetic Effect by Improving Insulin Release in Type 2 Diabetic Goto-Kakizaki Rats.提取物通过改善 2 型糖尿病 Goto-Kakizaki 大鼠的胰岛素释放来发挥抗糖尿病作用。
Nutrients. 2018 Jul 20;10(7):933. doi: 10.3390/nu10070933.
10
Antidiabetic effect of chronic administration of JTT-608, a new hypoglycemic agent, in diabetic Goto-Kakizaki rats.新型降糖药JTT - 608长期给药对糖尿病Goto - Kakizaki大鼠的抗糖尿病作用
Eur J Pharmacol. 2003 Aug 22;476(1-2):159-66. doi: 10.1016/s0014-2999(03)02120-4.
本文引用的文献
1
Drug discovery today: no molecules required.当今的药物发现：无需分子。
BMJ Evid Based Med. 2019 Apr;24(2):48-52. doi: 10.1136/bmjebm-2018-111121. Epub 2018 Dec 6.
2
The phenomenon of released-activity. Reply on comment on Don et al.: Dose-dependent antiviral activity of released-active form of antibodies to interferon-gamma against influenza A/California/07/09(H1N1) in murine model.释放活性现象。对 Don 等人的评论的回复：在小鼠模型中，释放活性形式的针对干扰素-γ的抗体对甲型流感/加利福尼亚/07/09（H1N1）的剂量依赖性抗病毒活性。
J Med Virol. 2017 Jul;89(7):1127-1130. doi: 10.1002/jmv.24759. Epub 2017 Feb 27.
3
[The phenomenon of release activity and the hypothesis of "spatial" homeostasis].[释放活动现象与“空间”稳态假说]
Usp Fiziol Nauk. 2013 Jul-Sep;44(3):54-76.
4
The novel oral drug Subetta exerts an antidiabetic effect in the diabetic Goto-Kakizaki rat: comparison with rosiglitazone.新型口服药物 Subetta 在糖尿病 Goto-Kakizaki 大鼠中发挥抗糖尿病作用：与罗格列酮的比较。
J Diabetes Res. 2013;2013:763125. doi: 10.1155/2013/763125. Epub 2013 May 8.
5
Study of hypoglycemic activity of Subetta and rosiglitazone on the model of streptozotocin-induced diabetes mellitus in rats.舒贝塔和罗格列酮对链脲佐菌素诱导的大鼠糖尿病模型降血糖活性的研究。
Bull Exp Biol Med. 2012 May;153(1):54-6. doi: 10.1007/s10517-012-1641-8.
6
Modeling disease progression and rosiglitazone intervention in type 2 diabetic Goto-Kakizaki rats.模拟 2 型糖尿病 Goto-Kakizaki 大鼠的疾病进展和罗格列酮干预。
J Pharmacol Exp Ther. 2012 Jun;341(3):617-25. doi: 10.1124/jpet.112.192419. Epub 2012 Feb 29.
7
Effects of antidiabetic drugs in high-fat diet and streptozotocin-nicotinamide-induced type 2 diabetic mice.抗糖尿病药物在高脂肪饮食和链脲佐菌素-烟酰胺诱导的 2 型糖尿病小鼠中的作用。
Eur J Pharmacol. 2011 Mar 25;655(1-3):108-16. doi: 10.1016/j.ejphar.2011.01.015. Epub 2011 Jan 23.
8
Improvement of Memory by Means of Ultra-Low Doses of Antibodies to S-100B Antigen.通过使用 S-100B 抗原的超低剂量抗体来改善记忆。
Evid Based Complement Alternat Med. 2006 Dec;3(4):541-5. doi: 10.1093/ecam/nel073.
Zotero 插件